Sirio Pharma Co., Ltd. (300791.SZ)
CNY 28.09
(-0.46%)
CNY 28.09
(-0.46%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 282.02 Million CNY | 6.4% |
| 2022 | 265.05 Million CNY | -8.54% |
| 2021 | 289.81 Million CNY | -8.17% |
| 2020 | 315.61 Million CNY | 108.06% |
| 2019 | 151.69 Million CNY | -33.54% |
| 2018 | 228.23 Million CNY | 81.3% |
| 2017 | 125.88 Million CNY | -86.51% |
| 2016 | 933.06 Million CNY | 1238.88% |
| 2015 | 69.69 Million CNY | -5.87% |
| 2014 | 74.03 Million CNY | 6.24% |
| 2013 | 69.69 Million CNY | 27.12% |
| 2012 | 54.82 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 72.91 Million CNY | -13.68% |
| 2024 Q3 | 74.11 Million CNY | -17.12% |
| 2024 Q2 | 115.62 Million CNY | 58.58% |
| 2023 Q1 | 24.96 Million CNY | -54.53% |
| 2023 FY | 282.02 Million CNY | 6.4% |
| 2023 Q4 | 84.46 Million CNY | -10.73% |
| 2023 Q3 | 94.62 Million CNY | 21.35% |
| 2023 Q2 | 77.97 Million CNY | 212.33% |
| 2022 FY | 265.05 Million CNY | -8.54% |
| 2022 Q4 | 54.9 Million CNY | -31.42% |
| 2022 Q2 | 112.35 Million CNY | 533.11% |
| 2022 Q1 | 17.74 Million CNY | -66.36% |
| 2022 Q3 | 80.05 Million CNY | -28.75% |
| 2021 FY | 289.81 Million CNY | -8.17% |
| 2021 Q1 | 71.51 Million CNY | -21.96% |
| 2021 Q2 | 101.97 Million CNY | 42.59% |
| 2021 Q3 | 63.56 Million CNY | -37.66% |
| 2021 Q4 | 52.75 Million CNY | -17.0% |
| 2020 Q2 | 97.25 Million CNY | 73.44% |
| 2020 Q4 | 91.64 Million CNY | 29.72% |
| 2020 Q1 | 56.07 Million CNY | 121.78% |
| 2020 Q3 | 70.64 Million CNY | -27.36% |
| 2020 FY | 315.61 Million CNY | 108.06% |
| 2019 Q3 | 35.48 Million CNY | -30.78% |
| 2019 FY | 151.69 Million CNY | -33.54% |
| 2019 Q1 | 39.66 Million CNY | -47.06% |
| 2019 Q2 | 51.25 Million CNY | 29.22% |
| 2019 Q4 | 25.28 Million CNY | -28.74% |
| 2018 Q4 | 74.92 Million CNY | 24.66% |
| 2018 Q3 | 60.1 Million CNY | 0.0% |
| 2018 FY | 228.23 Million CNY | 81.3% |
| 2017 FY | 125.88 Million CNY | -86.51% |
| 2016 FY | 933.06 Million CNY | 1238.88% |
| 2015 Q4 | 5.86 Million CNY | 0.0% |
| 2015 FY | 69.69 Million CNY | -5.87% |
| 2014 FY | 74.03 Million CNY | 6.24% |
| 2013 FY | 69.69 Million CNY | 27.12% |
| 2012 FY | 54.82 Million CNY | 0.0% |